Furosemide ‘Myths’ Discussed at HBPA Convention
Tom LaMarra
January 16, 2012
Panelists said there is no scientific evidence supporting a ban on the use of furosemide on race day.
Panelists said there is no scientific evidence supporting a ban on the use of furosemide on race day.
Furosemide, known as Salix, will be discussed Jan. 14 during the National HBPA Medication Committee forum.
This must be broached delicately so it is reversible and doesn’t impart any detrimental effects on fertility.
The British Horseracing Authority announced in late 2011 four new detection times for common medications.
The Equine Health, Welfare, Integrity, and Research Subcommittee released a statement on welfare in racing.
The FEI’s new system allows external parties to submit suggestions for the 2013 Prohibited Substance List.
New rules prohibit private veterinarians from administering furosemide (Salix) to Thoroughbreds on race day.
From March 21 to April 1 28 horses tested positive for oxymetazoline–a prohibited topical nasal decongestant.
Effective Dec. 1, individuals competing in USEF-sanctioned events must be aware of new rules on NSAID useage.
The meeting began with several presentations on furosemide and EIPH, the condition the medication treats.
The Race Day Medication Committee is debating whether therapeutic medications such as Salix should be banned.
NSAID administration, the use of flunixin, and anabolic steroid classification are among the noted changes.
Recommended changes include raising the minimum equine age allowed to run and expanded veterinary inspections.
Prominent Thoroughbred owner George Strawbridge Jr. said racing can only grow by eliminating medications.
The money will help develop detection methods for and study the effects of ITPP, a performance enhancing drug.
New policies regarding veterinarians’, stewards’, and other officials’ race day roles have been introduced.
Stay on top of the most recent Horse Health news with
